Setting the 2nd Panel Straight on Discounting

Setting the 2nd Panel Straight on Discounting

A guest post by Mike Paulden, Health Economist from the University of Alberta, and Dr. James F. O’Mahony, Health Economist...

#PharmEconFriday: Cost-of-Illness (COI)

#PharmEconFriday: Cost-of-Illness (COI)

I recently had the opportunity to work with a couple amazing economists on a little project investigating whether the methods...

#PharmEconFriday: Budget Impact Analysis

#PharmEconFriday: Budget Impact Analysis

In the world of pharmacoeconomics, a budget impact analysis (BIA) or budget impact model (BIM) refers to the framework to...

#PharmEconFriday: The QALY

#PharmEconFriday: The QALY

“QALY” is one of the first terms students will learn in an introductory course on pharmacoeconomics.  It is an acronym...

#PharmEconFriday: The Markov Model

#PharmEconFriday: The Markov Model

Over the next few years, my career will shift focus to pharmacoeconomics (#PharmEcon) research and further away from pharmacy management...

All original content on these pages is fingerprinted and certified by Digiprove